Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
2022 · Nature · 126 citations
https://doi.org/10.1038/s41586-022-05066-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
227
Citations
5
h-index
5
i10-index
Julia Yemelyanenko is an academic researcher from Utrecht University. The author has contributed to research in topics: Fibroblast Growth Factor Research & Kruppel-like factors research & Bone health and treatments. The author has an h-index of 5, co-authored 21 publications.
ORCID: 0000-0001-9697-2039Click to start Chat